Nautilus Biotechnology, Inc. Reclassifications of Temporary to Permanent Equity
Nautilus Biotechnology, Inc. (NAUT) reported Reclassifications of Temporary to Permanent Equity of $1.77 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Shareholders' Equity
us-gaap:ReclassificationsOfTemporaryToPermanentEquity · last filed 2021-05-13
- Nautilus Biotechnology, Inc. reclassifications of temporary to permanent equity for the quarter ending 2021-03-31 was $1.77M.
| Period end | Reclassifications of Temporary to Permanent Equity 3 month |
|---|---|
| 2021-03-31 | $1.77M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |